• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Moderate Coffee Consumption Improves Aortic Distensibility in Hypertensive Elderly Individuals


Stockholm, Sweden, 31 August: A detailed study conducted by a team from the University of Athens on the Aegean island of Ikaria has demonstrated that moderate consumption of coffee by hypertensive elderly individuals can lead to improvements in aortic distensibility. Distensibility is a measure of the elasticity of arteries, and low levels have long been recognised as an indicator of atherosclerosis and a reliable predictor of future cardiovascular events. By increasing the load on the heart, hypertension leads to vascular changes and neurohormonal activation which causes increases in vascular stiffness and reduced elasticity.

Between June and October 2009, researchers from the University of Athens conducted a health and nutrition survey using a target group of 343 men and 330 women aged between 65 and 100 — all of whom were long-term residents of Ikaria. The island was selected because of its population’s high life expectancy, with an above-average proportion of residents over 90 years of age. Consideration was given to a wide range of socio-demographic, bioclinical, lifestyle and dietary characteristics related to cardiovascular risk factors such as hypertension, diabetes, hypercholesterolemia, obesity and anthropometric indices. Physical activity status and biochemical parameters related to cardiovascular risk were also evaluated.

Coffee consumption was particularly measured during the initial phase of the study because it is a deeply embedded social tradition within the Greek population, and also because of conflicting evidence of its impact on cardiovascular health. Doctor Christina Chrysohoou, the study coordinator, noted, “As far as the effect of coffee on hypertension is concerned, the pressor response to caffeine seems to be more pronounced in hypertensive or hypertension-prone subjects than in normotensive ones. For this reason, our study became focused on a subgroup of some 235 hypertensive subjects, and we measured the impact of daily coffee consumption using echocardiographic indices of aortic distensibility.”

To be classified within this sub-group of 235 individuals, subjects had to meet certain criteria that included a known history of hypertension, that they were under dietary or medical treatment, or that they had average blood-pressure levels above the upper limit of the normal range. Aortic distensibility for each of these 235 residents was calculated non-invasively by an established mathematical equation using the echocardiographic measurements of systolic and diastolic diameters of aortic root. Dietary habits were evaluated using a special, repeatable, semi-quantitative food-frequency questionnaire that had been previously validated by experts within the University of Athens in collaboration with the Nutrition Science and Dietetics Department of Harokopio University.

The analysis conclusively illustrates the beneficial effects on aortic distensibility of moderate coffee consumption. The research attributes this to the polyphenolic compounds found in coffee, especially traditional Greek blends that are high in diterpenes such as cafestol and kahweol. The effect of chlorogenic acid is reported to be associated with nitric oxide, as caffeic and ferulic acids appear to improve vascular function by reducing oxidation and enhancing the bio-availability of nitric oxide. Moreover, other micronutrients, including flavonoids, magnesium, potassium, niacin and vitamin E, contribute to the observed health effects of coffee consumption, mainly because of their anti-oxidant properties. However, in hypertensive patients the balance between nitric oxide and superoxide production is already damaged, so the impact of the beneficial compounds present in coffee is possibly not strong enough to offer a protective effect through increased consumption.

Doctor Chrysohoou summarises the findings, “The study revealed that moderate coffee consumption (between one and two cups per day) is associated with higher values of aortic distensibility when compared with other hypertensive elderly individuals taking less quantities of coffee. Adjustments were made for various factors such as age, gender, physical activity status, creatinine levels, BMI and diabetes mellitus. There was also evidence that moderate coffee consumption leads to reduced cardiovascular disease, lower prevalence of diabetes and hyperlipidaemia, lower body mass index, better renal functions and higher creatinine clearance levels. There was no evidence, however, that increasing coffee consumption to three to five cups per day would lead to further improvements in aortic distensibility.”

Contributors: Christina Chrysohoou, Kyriakos Dimitriadis, Dimitris Maragiannis, Dimitris Roussos, George Lazaros, Marina Zaromitidou, Georgia Vogiatzi, Gerassimos Siasos, Christos Pitsavos and Christodoulos Stefanadis – 1st Cardiology Clinic, University of Athens, Greece.

Author: Doctor Christina Chrysohoou, E-mail: chrysohoou@usa.net

For background information or independent comment, contact the ESC Press Office: E-mail: press@escardio.org

image description image description


				

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications